Medicine vs Food: The Patient Care Dilemma of Financial Toxicity
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Breast Cancer News
BREAST CANCER ADVISOR
Breast Cancer News
AEs Related to Antibody-Drug Conjugates Most Common in Breast Cancer
Researchers have characterized treatment-related adverse events associated with antibody-drug conjugates in clinical trials.
Clinical Trial: Trastuzumab-Based Combinations in HER2+ Breast Cancer
Researchers are conducting a phase 2 study to compare trastuzumab-based treatment regimens in patients with advanced HER2+ breast cancer.
Clinical Trial: Capecitabine Plus Cemiplimab in HR+ Metastatic Breast Cancer
Researchers are conducting a phase 1 study to test capecitabine in combination with cemiplimab in patients with HR+ metastatic breast cancer.
Clinical Trial: Can ctDNA Guide Treatment in High-Risk, ER+/HER2- Breast Cancer?
Researchers are conducting a phase 2 study to determine if ctDNA can be used to guide treatment in patients with ER+, HER2- breast cancer at high risk of recurrence.
Clinical Trial: Durvalumab Plus Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
Researchers are conducting a phase 2 study to test the safety and efficacy of durvalumab in combination with trastuzumab and pertuzumab for HER2-enriched breast cancer.
Cancer Screening and Detection Remain Below Prepandemic Levels
Screening for breast, cervical, and colorectal cancer decreased from prepandemic levels in early 2020, rebounded in late 2020, and decreased again in 2021.
ART Preferred Over ALND in Sentinel Node-Positive Early Breast Cancer
Axillary radiotherapy can replace axillary lymph node dissection in patients with sentinel node-positive early breast cancer, according to researchers.
Even Moderate Exercise Linked to Reduced Mortality After Breast Cancer
Breast cancer survivors who were active or moderately active had significantly reduced risk of death.
18F-NaF PET-CT More Accurate Than 99mTc-MDP SPECT for Detecting Bone Metastasis
Results of a phase 3 trial suggest 18F-NaF PET-CT is more effective than 99mTc-MDP SPECT for detecting bone metastasis in patients with breast or prostate cancer.
Dose-Dense Adjuvant Chemotherapy “Optimal” for High-Risk Early Breast Cancer
Dose-dense adjuvant chemotherapy improves disease-free survival in high-risk early breast cancer, according to updated results from the GIM2 trial.
Acupuncture Reduces Aromatase Inhibitor-Related Joint Pain in Breast Cancer Patients
Acupuncture can reduce aromatase inhibitor-related joint pain in women with early breast cancer, a study suggests.
Adjuvant Abemaciclib Improves iDFS, DRFS in High-Risk Early Breast Cancer
Adding abemaciclib to adjuvant endocrine therapy improves outcomes in patients with high-risk early breast cancer, data suggest.
Duration of ET Tied to Benefit in DCIS, but Young Patients May Reject ET
Two new studies shed light on the complexity of preventing subsequent breast cancer events in patients with ductal carcinoma in situ.
No Difference in OS With Margetuximab vs Trastuzumab in HER2+ Breast Cancer
Margetuximab does not provide an overall survival benefit over trastuzumab in patients with previously treated, HER2-positive breast cancer, a phase 3 trial suggests.
Overall Cancer Mortality 18% Higher in American Indians/Alaska Natives
Breast and prostate cancer mortality rates were higher in AIAN individuals than in White individuals, despite lower incidence rates.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
SBRT for Oligoprogression Improves Outcomes in NSCLC but Not Breast Cancer
Treating oligoprogression with SBRT improved progression-free survival in patients with lung cancer but not in those with breast cancer.
Radiotherapy of Asymptomatic Bone Metastases Reduces Skeletal-Related Events
Prophylactic radiotherapy of asymptomatic bone metastases can reduce skeletal-related events and improve survival in patients with solid tumors, a study suggests.
Some Women With Early-Stage Breast Cancer May Safely Forgo Surgery
Omission of surgery may be possible for women with early-stage breast cancer who are exceptional responders to neoadjuvant systemic therapy.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Breast Cancer News
Loading... 
Loading...